Market Overview:
The global automated nucleic acid extraction systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for nucleic acid extraction systems in hospitals, diagnostic centers, pharmaceutical & biotechnology companies, academic research institutes and others. Additionally, the growing focus on precision medicine is also contributing to the growth of this market.
Product Definition:
An automated nucleic acid extraction system (ANAE) is a machine that automates the process of extracting DNA or RNA from biological samples. The importance of ANAE systems lies in their ability to extract nucleic acids from a variety of sample types quickly and efficiently, allowing for more reliable and accurate results.
Fully Automated:
Fully automated nucleic acid extraction systems are used for the isolation of nucleic acids from a wide range of biological samples. These systems provide high-quality and reproducible results, which increases their applicability in research and development activities. The factors that propel the growth of this market include increasing demand for automation in laboratories, rising number of biotechnology companies, government funding to promote R&D activities related to genomics & proteomics and technological advancements such as miniaturization & portability.
Semi-automated:
Semi-automated systems are used in the automated nucleic acid extraction systems. These instruments are designed for laboratories that have moderate to high sample throughput requirements and where manual intervention is required at certain points during the process but overall, speed of automation is desired.
These instruments can be used with small as well as large scale projects and can also be integrated into larger automation platforms.
Application Insights:
The hospitals application segment accounted for the largest revenue share in 2016 and is anticipated to continue its dominance over the forecast period. Automated nucleic acid extraction systems are used extensively in hospitals for various applications, such as diagnostics testing, research studies, and drug discovery & development. The growing adoption of these systems at a global level has led to an increase in their demand within this segment.
The others application segment includes research institutes and academic laboratories. These organizations conduct extensive research on genetic diseases, cancer etiology and molecular mechanisms among others using DNA/RNA samples as primary sources of information.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, high disposable income, and increasing investments in R&D activities. Moreover, growing adoption of automated nucleic acid extraction systems by clinical laboratories for drug testing is expected to drive the regional demand over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and initiatives taken by governments across various countries for improving healthcare facilities in their respective nations. In addition, increasing prevalence of chronic diseases such as cancer and diabetes are also expected boost revenue generation from ANAES techniques during the forecast period in this region as these diseases are highly dependent on diagnostic procedures using automated equipment like Automated Nucleic Acid Extraction Systems (ANAES). Furthermore, a rise in government funding towards genomic research has led major pharmaceutical companies including Roche Diagnostics Corporation; Illumina; Bio-Rad Laboratories Inc.; Beckman Coulter Inc.
Growth Factors:
- Increasing demand for nucleic acid extraction from various sample types
- Technological advancements in automated nucleic acid extraction systems
- Growing application of automated nucleic acid extraction systems in life sciences research and diagnostics laboratories
- Rising demand for fast, accurate, and reliable nucleic acid extraction methods
- Increasing funding for life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
Automated Nucleic Acid Extraction Systems Market Research Report
By Type
Fully Automated, Semi-automated
By Application
Hospitals, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Others
By Companies
Qiagen, Roche Molecular Systems, Analytik Jena, Thermofisher Scientific, Accubiomed, Sansure Biotech, DiagCor Bioscience, Taigen Bioscience Corporation, Bioneer Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Automated Nucleic Acid Extraction Systems Market Report Segments:
The global Automated Nucleic Acid Extraction Systems market is segmented on the basis of:
Types
Fully Automated, Semi-automated
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qiagen
- Roche Molecular Systems
- Analytik Jena
- Thermofisher Scientific
- Accubiomed
- Sansure Biotech
- DiagCor Bioscience
- Taigen Bioscience Corporation
- Bioneer Corporation
Highlights of The Automated Nucleic Acid Extraction Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automated
- Semi-automated
- By Application:
- Hospitals
- Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automated Nucleic Acid Extraction Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Automated nucleic acid extraction systems are machines that use a variety of techniques to extract DNA and RNA from biological samples. These systems can be used to extract DNA from blood, saliva, hair, or other tissues. They can also be used to isolate specific gene sequences from genomic DNA samples.
Some of the major players in the automated nucleic acid extraction systems market are Qiagen, Roche Molecular Systems, Analytik Jena, Thermofisher Scientific, Accubiomed, Sansure Biotech, DiagCor Bioscience, Taigen Bioscience Corporation, Bioneer Corporation.
The automated nucleic acid extraction systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Automated Nucleic Acid Extraction Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Automated Nucleic Acid Extraction Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Automated Nucleic Acid Extraction Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Automated Nucleic Acid Extraction Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Automated Nucleic Acid Extraction Systems Market Size & Forecast, 2020-2028
4.5.1 Automated Nucleic Acid Extraction Systems Market Size and Y-o-Y Growth
4.5.2 Automated Nucleic Acid Extraction Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fully Automated
5.2.2 Semi-automated
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Pharmaceutical & Biotechnology Companies
6.2.4 Academic Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Automated Nucleic Acid Extraction Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Automated Nucleic Acid Extraction Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fully Automated
9.6.2 Semi-automated
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Pharmaceutical & Biotechnology Companies
9.10.4 Academic Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fully Automated
10.6.2 Semi-automated
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Pharmaceutical & Biotechnology Companies
10.10.4 Academic Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fully Automated
11.6.2 Semi-automated
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Pharmaceutical & Biotechnology Companies
11.10.4 Academic Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fully Automated
12.6.2 Semi-automated
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Pharmaceutical & Biotechnology Companies
12.10.4 Academic Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fully Automated
13.6.2 Semi-automated
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Pharmaceutical & Biotechnology Companies
13.10.4 Academic Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Automated Nucleic Acid Extraction Systems Market: Competitive Dashboard
14.2 Global Automated Nucleic Acid Extraction Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Qiagen
14.3.2 Roche Molecular Systems
14.3.3 Analytik Jena
14.3.4 Thermofisher Scientific
14.3.5 Accubiomed
14.3.6 Sansure Biotech
14.3.7 DiagCor Bioscience
14.3.8 Taigen Bioscience Corporation
14.3.9 Bioneer Corporation
